Former Director General of Pharmaceutical Safety Bureau at Korea Ministry of Food and Drug Safety

Involved in R&D and regulatory reform, ICH and IFAPP management committee,  Leadership roles  in various Pharmaceutical Medicine Society (e.g. KSCPT, KSPM, KSME)

Worked over 20 years  for various Pharmaceuticals as Medical/Scientific Affairs Director at MSD,  Sanofi,  Handok, and Pfizer

Ph.D. in Pharmacology at Hanyang University

MS of Preventive Medicine at Seoul National University

Bachelor of Medicine at Seoul National University

Head of Research and Development at Ildong Pharmaceutical Co., Ltd.

CEO at AIMS BioScience, a subsidiary company of Ildong Group 

Chairman of Korea Society of Pharmaceutical Medicine

Multiple roles of prior company as an executive director at J&J Korea, engaged in various R&D projects, clinical operations, medical advisor and commercial unit

Adjunctive Professor at Youth and Child psychiatry at SMC (Samsung Medical Center), served as medical director at National Center for Mental Health

Bachelor of Medicine at Seoul National University

Chief Operating Officer at Ildong Pharmaceutical Co., Ltd.

Former Chief Finance Officer at Dongwon F&B and Janssen Korea (Johnson & Johnson) with multi-disciplinary project , supply chain improvement and optimizing back office operation

MBA, Darden School of Business at University of Virginia, CPA in Maryland, US

Bachelor of Business Administration at Seoul National University

Total 15 years of industry experience, of which more than 10 years have been solely dedicated to Oncology clinical development

Former Oncology Project Lead at Pfizer Korea

Former Oncology Project Manager, Project Director and Customer Relationship Executive at Syneos Health

Provided consultancy to numerous oncology biotechs

Bachelor’s degree in pharmaceutical studies and master’s degree in pharmacology at Ewha Woman’s University

Registered pharmacist

15 years of industry experience, including 7 years of  medical lead of multinational clinical trials in hemato-oncology area

Early / late phase global clinical development for oncology area as Sr. Medical Director / Chief Medical Officer at Sillajen and Archigen

Medical Affairs Director for diverse therapeutic area including cardiovascular metabolism and immunology at Sanofi, Novartis, and Abbott

Multiple hands-on experience of clinical trial start-ups from synopsis development into regulatory IND approval in Korea, US and EU

Ph.D. of Public Health (Epideimiology) & Bachelor of Medicine at Yonsei University

Led RA/QA/PV with cross-functional projects at Guerbet Korea

Former RA/PV lead at SK Biopharmaceuticals

Handled a various type of registrations and product maintenance with the drug development experience from early stage

Worked at HIRA, involved in managing benefit standard and benefit adequacy

Master of Public Health at Yonsei University & Bachelor of pharmacy at Ewha Woman’s University

Registered pharmacist, Korea Regulatory Affair Certificate

Chief Globalization Officer at Ildong Pharmaceutical Co., Ltd

Former Chief Executive Officer at Yungjin Pharmaceutical Co., Ltd

Former Senior VP in Global Business Headquarter at Dong-A ST/Dong-A Socio Holdings

Former Senior Director at GlaxoSmithKline, PLC

MBA, University of Michigan, Executive Business School

Bachelor of Applied Science at University of British Columbia